) has been revised to $164.50 / share. This is an increase of 10.46% from the prior estimate of $148.92 dated February 21, 2026. The price target is an average of many targets provided by analysts.

TD Cowen maintained its ‘Buy’ rating on TransMedics with a $120 price target.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Is TMDX a good stock to buy? We came across a bullish thesis on TransMedics Group, Inc. on The Cash Flow Compounder’s Substack. In this article, we will summarize the bulls’ thesis on TMDX.

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. TransMedics Group, Inc. (NASDAQ:TMDX) is one of the best healthcare stocks on our list. TheFly reported on July 6 ...

TransMedics Group (NASDAQ:TMDX) has outperformed the market over the past 5 years by 29.61% on an annualized basis producing an average annual return of 42.0%. Currently, TransMedics Group has a ...

Specializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing ...

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. TransMedics Group, Inc. (NASDAQ:TMDX) is one of the best healthcare stocks on our list. TheFly reported on July 6 ...